The grades of four Medical Devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This week, Spectranetics (NASDAQ:SPNC) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system, many of which are used with its proprietary excimer laser system. In Portfolio Grader’s specific subcategories of Earnings Revisions and Earnings Surprise, SPNC also gets A’s. For more information, get Portfolio Grader’s complete analysis of SPNC stock.
Abiomed (NASDAQ:ABMD) shows solid improvement this week. The company’s rating rises from a B to an A. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.
EnteroMedics (NASDAQ:ETRM) is making progress this week as its rating of C (“hold”) from last week increases to a B (“buy”) rating this week. EnteroMedics is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders. For more information, get Portfolio Grader’s complete analysis of ETRM stock.
China Kanghui (NYSE:KH) earns a B this week, jumping up from last week’s grade of C. China Kanghui produces trauma supplies including nails, plates and screws, and cranial maxillofacial plate and screw systems, and spinal products including screws, meshes, interbody cages, and fixation systems. For more information, get Portfolio Grader’s complete analysis of KH stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
